Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Despite ...

Karina Ureña was fit, health-conscious and preparing to run her first marathon. But after the 30-year-old went to doctors, ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

An economic evaluation found that screening followed by intensive lifestyle intervention plus either semaglutide (Ozempic, ...

Q3 2025 Earnings Call Transcript November 4, 2025 Corcept Therapeutics Incorporated misses on earnings expectations. Reported ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

Berberine is a bright yellow medicinal powder made from different plants. It may offer several benefits, including improved blood sugar levels, reduced cholesterol, and support for weight loss.

Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

Experts have finally uncovered a 'big bang' moment which determines how bowel cancer will grow, in landmark research ...

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...